Risk of Myocardial Infarction in Patients with HIV Infection Exposed to Specific Individual Antiretroviral Drugs from the 3 Major Drug Classes: The Data Collection on Adverse Events of Anti‐HIV Drugs (D:A:D) StudySigne Westring Worm, Jens Lundgren, Stéphane De Wit et al.|The Journal of Infectious Diseases|2009Cited by 649
Implementing the number needed to harm in clinical practice: risk of myocardial infarction in HIV‐1‐infected patients treated with abacavirJustyna Kowalska, Jens Lundgren, Ole Kirk et al.|HIV Medicine|2009Cited by 15
Incoming HIV virion-derived Gag Spacer Peptide 2 (p1) is a target of effective CD8+ T cell antiviral responsesHongbing Yang, Fleur Hudson, Anuska Llano et al.|Cell Reports|2021Cited by 4